DNA adduct level in lung tissue may act as a risk biomarker of lung cancer

By Cheng Y.-W.   Chen C.-Y.   Lin P.   Chen C.-P.   Huang K.H.   Lin T.-S.   Wu M.-H.   Lee H.  

European Journal of Cancer, Vol. 36, Iss. 11, 2000-07 ,pp. : 1381-1388

Elsevier

Access to resources Recommend Favorite

Polymorphisms in the vitamin D receptor gene and the lung cancer risk

By Fu Yingjv   Li Junrui   Zhang Yuanyue  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1323-1330

Springer Publishing Company

Access to resources Recommend Favorite

Elevated expression level of laminin 5 may be a negative predictive factor for the response to gefitinib in lung cancer patients

By An Shejuan  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 12, 2008-12 ,pp. : 677-681

Springer Publishing Company

Access to resources Recommend Favorite

Quantitative assessment of the influence of common variations (rs8034191 and rs1051730) at 15q25 and lung cancer risk

By Hu Bin   Huang Ying   Yu Rong-huan   Mao Hong-ju   Guan Chao   Zhao Jing  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2777-2785

Springer Publishing Company

Access to resources Recommend Favorite

An inflammatory response with worsening of pleural effusion on treatment with erlotinib in non-small cell lung cancer

By Toh Chee-Keong   Lee Pyng   Chowbay Balram   Goh Jason   Mancer Kent   Tan Puay-Hoon  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 256-258

Informa Healthcare

Access to resources Recommend Favorite